The safety of rituximab for the treatment of autoimmune blistering diseases: A systematic review

Simple item page
dc.contributor.authorMohammed, Arooj
dc.contributor.authorHekman, Daniel
dc.contributor.authorLi, Wendy
dc.contributor.authorMisquith, Chelsea
dc.contributor.authorRahnama-Moghadam, Sahand
dc.contributor.departmentDermatology, School of Medicineen_US
dc.date.accessioned2022-02-04T22:26:22Z
dc.date.available2022-02-04T22:26:22Z
dc.date.issued2021
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationMohammed, A., Hekman, D., Li, W., Misquith, C., & Rahnama-Moghadam, S. (2021). The safety of rituximab for the treatment of autoimmune blistering diseases: A systematic review. Journal of the American Academy of Dermatology, S0190962221020077. https://doi.org/10.1016/j.jaad.2021.06.862en_US
dc.identifier.issn0190-9622en_US
dc.identifier.urihttps://hdl.handle.net/1805/27710
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.jaad.2021.06.862en_US
dc.relation.journalJournal of the American Academy of Dermatologyen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectadverse eventen_US
dc.subjectautoimmune blistering diseaseen_US
dc.subjectmonoclonal antibodyen_US
dc.subjectpemphigoiden_US
dc.subjectrituximaben_US
dc.titleThe safety of rituximab for the treatment of autoimmune blistering diseases: A systematic reviewen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mohammed2021TheSafety-AAM.pdf
Size:
137.28 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Dermatology Works